Defaults edge up in Fannie Mae multifamily
admin | December 11, 2020
This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors.
Across the agency multifamily spectrum, loans are exiting forbearance and a portion are beginning to default. Analyzing delinquency and default trends in Fannie Mae multifamily loans shows that a higher percentage of loans in DUS pools than in FNA deals have entered forbearance, and a small subset of those have already defaulted.
Fannie Mae’s multifamily book outstanding totals $360 billion, where 25% has been securitized on the FNA shelf and 75% is in DUS pools and types of whole loan REMICs (Exhibit 1). Overall, 1.86% of Fannie multifamily loans have been in forbearance at some point, with DUS pools somewhat overweight forbearance at 2.18% outstanding while only 0.89% of FNA shelf loans have been in forbearance. One explanation for the discrepancy is that there is only a single seniors housing loan in FNA deals, whereas more than 3% of DUS pools are seniors housing and a significant portion of those loans have sought forbearance during the pandemic.
Exhibit 1: Fannie Mae multifamily loans outstanding
Note: DUS and whole loan REMICs outstanding implied from calculations of total outstanding less FNA shelf. Source: FNA shelf loans outstanding from Bloomberg, updated 12/9/2020. Total multifamily loans outstanding from Fannie Mae, latest data as of 12/10/2020 forbearance report. Amherst Pierpont Securities
The initial period of forbearance offered was three months. As the crisis wore on, borrowers could apply for an extension for another three months for a total of six months of possible forbearance. The majority of borrowers that sought forbearance entered into agreements from April through May, and those loans have exited forbearance and are in the repayment period. So far 5.0% of DUS UPB that entered forbearance has defaulted or gone into workout and been repurchased by Fannie Mae (Exhibit 2). This is 11 bp of DUS and whole loan REMICs outstanding. More than 21% of loans in forbearance have already cured and 44% are currently in repayment.
Exhibit 2: Forbearance summary for DUS loans
Note: Fannie Mae forbearance report of 12/10/2020. Source: Fannie Mae, Bloomberg, Amherst Pierpont Securities
Assessing forbearance and default trends in loans securitized on the FNA shelf is a bit more difficult (Exhibit 3). Loans actively in forbearance are designated as performing and then are marked as delinquent once they exit the forbearance period. The payment status for many loans moves from current to 90+ days delinquent. As these loans cure over time they should move into the 60-day and then 30-day delinquency buckets. There is typically no watchlist commentary provided for these loans so its more difficult to assess which are moving towards default and which are curing forbearance.
Exhibit 3: Forbearance summary for FNA shelf loans
Source: Bloomberg, Amherst Pierpont Securities
What is clear is that the 71.3% of FNA shelf loans that sought forbearance are presumably in the repayment period. The 28.7% of loans that are performing could include a subset that have already cured forbearance entirely, similar to the DUS pools that resolved early. So far, there does not appear to be FNA shelf loans in workout or default, though some portion of the 90+ days delinquent loans stand to be repurchased.
This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.
Copyright © 2023 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.
In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.
The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.
In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.
Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.